Oregon Public Employees Retirement Fund’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,529
Closed -$483K 1714
2022
Q4
$483K Buy
14,529
+123
+0.9% +$3.96K 0.01% 1314
2022
Q3
$454K Buy
14,406
+92
+0.6% +$2.98K 0.01% 1301
2022
Q2
$435K Sell
14,314
-2,039
-12% -$55.1K 0.01% 1185
2022
Q1
$425K Sell
16,353
-300
-2% -$7.14K ﹤0.01% 1460
2021
Q4
$340K Sell
16,653
-800
-5% -$15.3K ﹤0.01% 1408
2021
Q3
$336K Sell
17,453
-100
-0.6% -$1.99K ﹤0.01% 1415
2021
Q2
$389K Hold
17,553
﹤0.01% 1392
2021
Q1
$461K Buy
17,553
+300
+2% +$7.13K 0.01% 1349
2020
Q4
$322K Sell
17,253
-270
-2% -$5.04K ﹤0.01% 1387
2020
Q3
$298K Buy
17,523
+500
+3% +$9.72K ﹤0.01% 1294
2020
Q2
$396K Hold
17,023
0.01% 1194
2020
Q1
$143K Hold
17,023
﹤0.01% 1415
2019
Q4
$166K Hold
17,023
﹤0.01% 1501
2019
Q3
$162K Buy
17,023
+300
+2% +$3.16K ﹤0.01% 1556
2019
Q2
$199K Buy
16,723
+300
+2% +$3.61K ﹤0.01% 1535
2019
Q1
$289K Buy
16,423
+297
+2% +$4.94K ﹤0.01% 1429
2018
Q4
$280K Buy
+16,126
New +$275K ﹤0.01% 1415

Other funds holding VIVO

Oregon Public Employees Retirement Fund's VIVO Position: Q1 2023 in Review

Oregon Public Employees Retirement Fund sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 14,529 shares — an estimated $483K sold.

Oregon Public Employees Retirement Fund first reported a position in VIVO in Q4 2018 and held it in 17 quarters. The position peaked at $483K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Oregon Public Employees Retirement Fund reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 14,529 Meridian Bioscience Inc shares in Q1 2023, an estimated $483K.
  • Oregon Public Employees Retirement Fund first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 17 quarters.
  • Oregon Public Employees Retirement Fund's Meridian Bioscience Inc position peaked at $483K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2023, filed 4 May 2023.